IGSF9B - immunoglobulin superfamily member 9B Gene
Also Known as LINC00947; MIR4697HG
Species: Homo sapiens
About IGSF9B
This gene has 7 transcripts (splice variants), 270 orthologues and 36 paralogues. Broad expression in brain (RPKM 1.7), testis (RPKM 1.1) and 21 other tissues.
Summary
Predicted to enable kinase binding activity. Predicted to be involved in synaptic membrane adhesion. Predicted to act upstream of or within homophilic cell adhesion via plasma membrane adhesion molecules and positive regulation of inhibitory postsynaptic potential. Predicted to be located in dendrite; inhibitory synapse; and neuronal cell body. Predicted to be active in GABA-ergic synapse; neuron projection; and postsynaptic specialization of symmetric synapse. [provided by Alliance of Genome Resources, Apr 2022]
IGSF9B Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001277285.4 | NP_001264214.1 | protein turtle homolog B precursor |
IGSF9B Protein Structure
V-set: Immunoglobulin V-set domain (29 - 131)
I-set: Immunoglobulin I-set domain (140 - 225)
I-set: Immunoglobulin I-set domain (230 - 321)
Ig_2: Immunoglobulin domain (328 - 413)
I-set: Immunoglobulin I-set domain (433 - 505)
fn3: Fibronectin type III domain (512 - 594)
fn3: Fibronectin type III domain (622 - 698)
- 0
- 300
- 600
- 900
- 1200
- 1349 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
protein turtle homolog B |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Ovarian Cancer |
|
|
| Tetralogy Of Fallot |
|
|
| Nervous System Disease |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS06653 | IGSF9B Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service